Long-term Prognosis in Stroke Patients

Acute Stroke Clinical Trial

Official title:

Long-term Prognosis in Stroke Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03510312
• Other study ID #: 4-2011-0731
• Status: Recruiting
• Start date: December 2011
• Est. completion date: December 2021

Study information

• Verified date: March 2021
• Source: Severance Hospital
• Contact: Ji Hoe Heo, MD, PhD
• Phone: 82-2-2228-1605
• Email: jhheo[@]yuhs.ac
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A single-center cohort of patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university and their long-term outcomes.

Description:

This is a single-center cohort of consecutive patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university in Republic of Korea.

Stroke recurrence, Cardiovascular event, all cause mortality and cardiovascular mortality were collected through long-term follow up.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 9000
• Est. completion date: December 2021
• Est. primary completion date: December 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All patients with acute ischemic stroke or transient ischemic attack

Exclusion Criteria:

• A patient who did not agree with enrollment of this study

Related Conditions & MeSH terms

• Acute Stroke
• Stroke

Locations

Country	Name	City	State
Korea, Republic of	Ji Hoe Heo	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Event of Stroke or transient ischemic attack	The time of a stroke or transient ischemic attack occurs (through study completion)	through study completion, up to 10 years
Primary	Event of cardiovascular disease (include stroke/transient ischemic attack)	The time of a cardiovascular disease (stroke/transient ischemic attack) occurs (through study completion)	through study completion, up to 10 years
Primary	All cause mortality	The time of death from any cause (through study completion)	through study completion, up to 10 years
Primary	Cardiovascular cause mortality (include stroke/transient ischemic attack mortality)	The time of death from cardiovascular cause (through study completion)	through study completion, up to 10 years
Primary	The modified Rankin Scale (mRS)	Measure functional outcome as the form of mRS at 3 months	3 months